Nadia Amboldi

1.3k total citations
24 papers, 577 citations indexed

About

Nadia Amboldi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nadia Amboldi has authored 24 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nadia Amboldi's work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Glioma Diagnosis and Treatment (2 papers). Nadia Amboldi is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Glioma Diagnosis and Treatment (2 papers). Nadia Amboldi collaborates with scholars based in Italy, Canada and United States. Nadia Amboldi's co-authors include Giampaolo Merlini, Vittorio Bellotti, Irene Zorzoli, E Ascari, Arturo Galvani, Vittorio Perfetti, Eloisa Arbustini, Pietro Garini, Marilyn E. Ferrari and Antonella Isacchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Nadia Amboldi

24 papers receiving 562 citations

Peers

Nadia Amboldi

ONCOL

PRM

PHYSI

RHEUM

Silvia Mateo‐Lozano Spain

Muzaffer Cicek United States

Kenneth E. Hook United States

Michael M. Lizardo United States

Philip Ryan United States

Gengjie Yang United States

Ramesh Butti India

Lorenzo Bombardelli Netherlands

Anja Rockstroh Australia

Olivia Gardner United States

Silvia Mateo‐Lozano Spain

Nadia Amboldi

511 ×1.4

263 ×1.4

ONCOL

308 ×2.0

PRM

33 ×0.3

PHYSI

32 ×0.5

RHEUM

Citations per year, relative to Nadia Amboldi Nadia Amboldi (= 1×) peers Silvia Mateo‐Lozano

Countries citing papers authored by Nadia Amboldi

Since Specialization

Citations

This map shows the geographic impact of Nadia Amboldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Amboldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Amboldi more than expected).

Fields of papers citing papers by Nadia Amboldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Amboldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Amboldi. The network helps show where Nadia Amboldi may publish in the future.

Co-authorship network of co-authors of Nadia Amboldi

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Amboldi. A scholar is included among the top collaborators of Nadia Amboldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Amboldi. Nadia Amboldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magnaghi, Paola, Barbara Salom, Liviana Cozzi, et al.. (2017). Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury. Molecular Cancer Therapeutics. 17(3). 603–613. 59 indexed citations

Bosotti, Roberta, Paola Magnaghi, Sebastiano Di Bella, et al.. (2017). Establishment and genomic characterization of the new chordoma cell line Chor-IN-1. Scientific Reports. 7(1). 9226–9226. 12 indexed citations

Brasca, Maria Gabriella, Paola Gnocchi, M. Nesi, et al.. (2015). Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders. Bioorganic & Medicinal Chemistry. 23(10). 2387–2407. 17 indexed citations

Pulici, Maurizio, Gabriella Traquandi, Chiara Marchionni, et al.. (2014). Optimization of Diarylthiazole B‐Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical Effect. ChemMedChem. 10(2). 276–295. 9 indexed citations

Casale, Elena, Nadia Amboldi, Maria Gabriella Brasca, et al.. (2014). Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. Bioorganic & Medicinal Chemistry. 22(15). 4135–4150. 34 indexed citations

Somaschini, Alessio, Nadia Amboldi, Angelo Nuzzo, et al.. (2013). Cell Line Identity Finding by Fingerprinting, an Optimized Resource for Short Tandem Repeat Profile Authentication. Genetic Testing and Molecular Biomarkers. 17(3). 254–259. 9 indexed citations

Golay, Josée, Clara Albanese, Roberta Ceruti, et al.. (2013). The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56+ Acute Monoblastic Leukaemia. PLoS ONE. 8(3). e58424–e58424. 30 indexed citations

Ardini, Elena, Maria Menichincheri, Patrizia Banfi, et al.. (2013). Abstract 2092: The ALK inhibitor NMS-E628 also potently inhibits ROS1 and induces tumor regression in ROS-driven models .. Cancer Research. 73(8_Supplement). 2092–2092. 9 indexed citations

Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2013). Anti‐tumour efficacy on glioma models of PHA‐848125, a multi‐kinase inhibitor able to cross the blood–brain barrier. British Journal of Pharmacology. 169(1). 156–166. 18 indexed citations

10.

Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2010). Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy. Molecular Cancer Therapeutics. 9(8). 2243–2254. 51 indexed citations

11.

Ardini, Elena, Andrea Borgia, Cristina Ponti, et al.. (2010). 102 Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer. European Journal of Cancer Supplements. 8(7). 39–40. 4 indexed citations

12.

Ardini, Elena, Maria Menichincheri, Cristina Ponti, et al.. (2009). Abstract A243: Characterization of NMS-E628, a small molecule inhibitor of anaplastic lymphoma kinase with antitumor efficacy in ALK-dependent lymphoma and non-small cell lung cancer models. Molecular Cancer Therapeutics. 8(12_Supplement). A244–A244. 27 indexed citations

13.

Alzani, Rachele, Clara Albanese, Giuseppe Locatelli, et al.. (2008). 294 POSTER Biological characterization of the dual CDK2/TRKA inhibitor PHA-848125. European Journal of Cancer Supplements. 6(12). 94–95. 1 indexed citations

14.

Villa, Anna, Antonio Papagni, L. Miozzo, et al.. (2005). Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. European Journal of Cancer. 41(10). 1453–1459. 17 indexed citations

15.

Palha, Joana Almeida, Dario Ballinari, Nadia Amboldi, et al.. (2000). 4′-Iodo-4′-Deoxydoxorubicin Disrupts the Fibrillar Structure of Transthyretin Amyloid. American Journal Of Pathology. 156(6). 1919–1925. 52 indexed citations

16.

Hanessian, Stephen, et al.. (2000). Design and synthesis of functionalized glycomers as non-peptidic ligands for SH2 binding and as inhibitors of A-431 human epidermoid and HT-29 colon carcinoma cell lines. Bioorganic & Medicinal Chemistry Letters. 10(5). 439–442. 13 indexed citations

17.

Quintieri, Luigi, Antonio Rosato, Nadia Amboldi, et al.. (1999). Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases. British Journal of Cancer. 79(7-8). 1067–1073. 4 indexed citations

18.

Merlini, Giampaolo, E Ascari, Nadia Amboldi, et al.. (1995). Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.. Proceedings of the National Academy of Sciences. 92(7). 2959–2963. 167 indexed citations

19.

Capolongo, Laura, Nadia Amboldi, Dario Ballinari, et al.. (1994). Reversal of Multidrug Resistance by New Dihydropyridines with Low Calcium Antagonist Activity. Acta Oncologica. 33(7). 787–791. 3 indexed citations

20.

Mandruzzato, Susanna, Antonio Rosato, Vincenzo Bronte, et al.. (1994). Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases.. PubMed. 54(4). 1016–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact